The human microbiota is associated with cardiometabolic risk across the epidemiologic transition.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
03
2019
accepted:
04
06
2019
entrez:
25
7
2019
pubmed:
25
7
2019
medline:
19
2
2020
Statut:
epublish
Résumé
Oral and fecal microbial biomarkers have previously been associated with cardiometabolic (CM) risk, however, no comprehensive attempt has been made to explore this association in minority populations or across different geographic regions. We characterized gut- and oral-associated microbiota and CM risk in 655 participants of African-origin, aged 25-45, from Ghana, South Africa, Jamaica, and the United States (US). CM risk was classified using the CM risk cut-points for elevated waist circumference, elevated blood pressure and elevated fasted blood glucose, low high-density lipoprotein (HDL), and elevated triglycerides. Gut-associated bacterial alpha diversity negatively correlated with elevated blood pressure and elevated fasted blood glucose. Similarly, gut bacterial beta diversity was also significantly differentiated by waist circumference, blood pressure, triglyceridemia and HDL-cholesterolemia. Notably, differences in inter- and intra-personal gut microbial diversity were geographic-region specific. Participants meeting the cut-points for 3 out of the 5 CM risk factors were significantly more enriched with Lachnospiraceae, and were significantly depleted of Clostridiaceae, Peptostreptococcaceae, and Prevotella. The predicted relative proportions of the genes involved in the pathways for lipopolysaccharides (LPS) and butyrate synthesis were also significantly differentiated by the CM risk phenotype, whereby genes involved in the butyrate synthesis via lysine, glutarate and 4-aminobutyrate/succinate pathways and LPS synthesis pathway were enriched in participants with greater CM risk. Furthermore, inter-individual oral microbiota diversity was also significantly associated with the CM risk factors, and oral-associated Streptococcus, Prevotella, and Veillonella were enriched in participants with 3 out of the 5 CM risk factors. We demonstrate that in a diverse cohort of African-origin adults, CM risk is significantly associated with reduced microbial diversity, and the enrichment of specific bacterial taxa and predicted functional traits in both gut and oral environments. As well as providing new insights into the associations between the gut and oral microbiota and CM risk, this study also highlights the potential for novel therapeutic discoveries which target the oral and gut microbiota in CM risk.
Identifiants
pubmed: 31339887
doi: 10.1371/journal.pone.0215262
pii: PONE-D-19-08653
pmc: PMC6656343
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0215262Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK111848
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Nat Med. 2018 Oct;24(10):1526-1531
pubmed: 30150717
J Pharmacol Sci. 2010;113(2):103-9
pubmed: 20501966
Cell Metab. 2013 Feb 5;17(2):225-35
pubmed: 23395169
ISME J. 2013 Apr;7(4):880-4
pubmed: 23235292
Nature. 2013 Aug 29;500(7464):541-6
pubmed: 23985870
Trends Microbiol. 2016 Jul;24(7):523-524
pubmed: 26996766
Nat Med. 2018 Sep;24(9):1407-1417
pubmed: 30082863
Nat Commun. 2013;4:1829
pubmed: 23652017
PLoS One. 2014 Oct 16;9(10):e109761
pubmed: 25329160
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Nature. 2006 Jan 26;439(7075):484-9
pubmed: 16400329
mBio. 2014 Apr 22;5(2):e00889
pubmed: 24757212
Annu Rev Med. 2015;66:343-59
pubmed: 25587655
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
Obstet Gynecol. 1997 Feb;89(2):257-60
pubmed: 9015031
Sci Rep. 2015 Nov 13;5:16643
pubmed: 26563823
Immunology. 2017 Aug;151(4):363-374
pubmed: 28542929
Nat Rev Nephrol. 2016 Mar;12(3):169-81
pubmed: 26616538
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
Gut. 2016 May;65(5):749-56
pubmed: 26719299
Sci Rep. 2018 Jan 12;8(1):635
pubmed: 29330424
J Periodontal Res. 2013 Feb;48(1):30-6
pubmed: 22762355
Genome Biol. 2016 Sep 26;17(1):189
pubmed: 27666579
Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14
pubmed: 22080510
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Sci Rep. 2018 Jul 27;8(1):11356
pubmed: 30054529
Int J Cardiol. 2013 Oct 12;168(5):4761-8
pubmed: 23972953
ISME J. 2015 Sep;9(9):1979-90
pubmed: 25647347
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2365-70
pubmed: 19164560
Diabetes. 2009 Jul;58(7):1509-17
pubmed: 19366864
J Leukoc Biol. 2006 Aug;80(2):267-77
pubmed: 16731773
Eur J Epidemiol. 2010 Jun;25(6):375-84
pubmed: 20425137
Obesity (Silver Spring). 2012 Jan;20(1):157-64
pubmed: 21996660
Nutrients. 2012 Jul;4(7):676-94
pubmed: 22852057
Nature. 2009 Jan 22;457(7228):480-4
pubmed: 19043404
J Ren Nutr. 2015 Jul;25(4):351-6
pubmed: 25802017
Microb Ecol Health Dis. 2015 May 29;26:27663
pubmed: 26028277
Br J Nutr. 2010 Feb;103(3):335-8
pubmed: 19849869
Cell Metab. 2009 Sep;10(3):167-77
pubmed: 19723493
Sci Rep. 2016 Oct 14;6:35405
pubmed: 27739530
PLoS One. 2011;6(6):e20944
pubmed: 21695273
J Infect Dis. 2002 Sep 15;186(6):798-806
pubmed: 12198614
Int J Obes (Lond). 2018 Mar;42(3):424-432
pubmed: 29142244
BMC Public Health. 2011 Dec 14;11:927
pubmed: 22168992
mSystems. 2015 Dec 22;1(1):
pubmed: 27822518
Nat Commun. 2012;3:1245
pubmed: 23212374
mBio. 2014 Aug 12;5(4):
pubmed: 25118238
Sci Rep. 2017 Aug 31;7(1):10277
pubmed: 28860611
Diabetes. 2007 Jul;56(7):1761-72
pubmed: 17456850
Prev Chronic Dis. 2017 Mar 16;14:E24
pubmed: 28301314
Cancer Res. 1967 Feb;27(2):209-20
pubmed: 6018555
Methods Mol Biol. 2018;1849:113-129
pubmed: 30298251
Nature. 2012 Aug 30;488(7413):621-6
pubmed: 22914093
Genome Biol Evol. 2014 Mar;6(3):703-13
pubmed: 24625961
Gut. 2014 Aug;63(8):1275-83
pubmed: 24021287
Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):503-14
pubmed: 20664519
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
pubmed: 16332807
J Am Soc Nephrol. 2017 Jan;28(1):321-331
pubmed: 27436853
Genome Med. 2016 Jun 15;8(1):67
pubmed: 27306058
PLoS One. 2016 Nov 7;11(11):e0166104
pubmed: 27820856
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Am J Clin Nutr. 1998 Oct;68(4):899-917
pubmed: 9771869
Nat Commun. 2017 Oct 10;8(1):845
pubmed: 29018189
PLoS One. 2010 Feb 05;5(2):e9085
pubmed: 20140211
Microbiome. 2015 Sep 03;3:38
pubmed: 26334731
ISME J. 2014 Nov;8(11):2218-30
pubmed: 24763370
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10679-84
pubmed: 15249654
Nat Med. 2013 May;19(5):576-85
pubmed: 23563705
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4592-8
pubmed: 20937873
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71
pubmed: 23671105
J Card Fail. 2015 Feb;21(2):91-6
pubmed: 25459686
Trends Endocrinol Metab. 2015 Jun;26(6):315-21
pubmed: 25892452
PLoS One. 2016 May 19;11(5):e0154990
pubmed: 27195697
AIDS. 2015 Nov 28;29(18):2409-18
pubmed: 26355675